# Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells

> **NCT01068951** · NA · COMPLETED · sponsor: **Uppsala University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT01068951
- **Lead sponsor:** Uppsala University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01068951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01068951, "Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01068951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*